Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...

Sanofi plans to send a letter, reviewed by WSJ, to hospitals outlining its new model on Friday, the report said, citing ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...

Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will ...

Sanofi is the third company - along with J&J and Eli Lilly - to attempt to change the way it pays for medicines under the ...

Regeneron Pharmaceuticals Inc. claims that a partner has broken a collaboration deal by refusing to reveal side deals for marketing ...

Sanofi's new plan will require institutions to provide pharmacy and medical claims information, such as the drug's order or a patient's hospital visit, before receiving federally mandated ...

An industry fight against lucrative drug discounts for hospitals is intensifying as another drugmaker joins the battle: Sanofi. The pharmaceutical company plans to change its policy on how it ...